Burroughs Wellcome and the Pricing of Azt (B)

The B case opens with Wellcome PLC's announcement of the wholesale price of AZT (see the A case, UVA-E-0074). The remainder of the case chronicles the responses of various groups involved in the AIDS crisis: Wellcome's investors, U.S. government officials, members of the medical community, and AIDS activists. The case concludes with Wellcome's defense of its pricing rationale. See also the C case (UVA-E-0076)

MoreLess

Year of publication:	[2008]
Authors:	Liedtka, Jeanne
Publisher:	[2008]: [S.l.] : SSRN

More details
Report error

Extent:	1 Online-Ressource (3 p)
Type of publication:	Book / Working Paper
Notes:	In: , Vol. , pp. 1-4
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10012774104